XTL Biopharmaceuticals Ltd (XTLB)
1.83
+0.06
(+3.39%)
USD |
NASDAQ |
Nov 21, 16:00
1.67
-0.16
(-8.74%)
After-Hours: 20:00
XTL Biopharmaceuticals Enterprise Value: 7.633M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 7.633M |
| November 20, 2024 | 7.306M |
| November 19, 2024 | 7.306M |
| November 18, 2024 | 7.197M |
| November 15, 2024 | 7.742M |
| November 14, 2024 | 7.578M |
| November 13, 2024 | 7.851M |
| November 12, 2024 | 7.851M |
| November 11, 2024 | 7.224M |
| November 08, 2024 | 7.687M |
| November 07, 2024 | 7.796M |
| November 06, 2024 | 7.524M |
| November 05, 2024 | 7.578M |
| November 04, 2024 | 7.905M |
| November 01, 2024 | 10.47M |
| October 31, 2024 | 9.867M |
| October 30, 2024 | 7.360M |
| October 29, 2024 | 7.142M |
| October 28, 2024 | 8.015M |
| October 25, 2024 | 6.107M |
| October 24, 2024 | 5.671M |
| October 23, 2024 | 5.235M |
| October 22, 2024 | 7.524M |
| October 21, 2024 | 8.314M |
| October 18, 2024 | 9.032M |
| Date | Value |
|---|---|
| October 17, 2024 | 9.486M |
| October 16, 2024 | 8.450M |
| October 15, 2024 | 8.505M |
| October 14, 2024 | 9.649M |
| October 11, 2024 | 9.649M |
| October 10, 2024 | 9.486M |
| October 09, 2024 | 9.594M |
| October 08, 2024 | 9.758M |
| October 07, 2024 | 10.19M |
| October 04, 2024 | 10.47M |
| October 03, 2024 | 10.74M |
| October 02, 2024 | 10.36M |
| October 01, 2024 | 10.90M |
| September 30, 2024 | 10.77M |
| September 27, 2024 | 11.61M |
| September 26, 2024 | 11.45M |
| September 25, 2024 | 11.77M |
| September 24, 2024 | 10.96M |
| September 23, 2024 | 10.85M |
| September 20, 2024 | 10.96M |
| September 19, 2024 | 10.85M |
| September 18, 2024 | 10.79M |
| September 17, 2024 | 11.01M |
| September 16, 2024 | 11.50M |
| September 13, 2024 | 11.99M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.100M
Minimum
Mar 27 2020
21.17M
Maximum
Sep 02 2021
6.965M
Average
5.280M
Median
Jul 28 2020
Enterprise Value Benchmarks
| Compugen Ltd | 17.12M |
| Pluri Inc | 31.05M |
| BioLine Rx Ltd | 15.23M |
| Can Fite Biofarma Ltd | 7.282M |
| BiomX Inc | 4.047M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.485M |
| Total Expenses (Quarterly) | 0.175M |
| EPS Diluted (Quarterly) | 0.10 |
| Earnings Yield | -1.71% |
| Normalized Earnings Yield | -28.44 |